175 related articles for article (PubMed ID: 33834434)
1. Clinically Compatible Fluorescence Microscopy Based on Moxifloxacin Antibiotic.
Lee S; Kim KH
Adv Exp Med Biol; 2021; 1310():91-113. PubMed ID: 33834434
[TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin: Clinically compatible contrast agent for multiphoton imaging.
Wang T; Jang WH; Lee S; Yoon CJ; Lee JH; Kim B; Hwang S; Hong CP; Yoon Y; Lee G; Le VH; Bok S; Ahn GO; Lee J; Gho YS; Chung E; Kim S; Jang MH; Myung SJ; Kim MJ; So PT; Kim KH
Sci Rep; 2016 Jun; 6():27142. PubMed ID: 27283889
[TBL] [Abstract][Full Text] [Related]
3. Two-photon microscopy of fungal keratitis-affected rabbit cornea ex vivo using moxifloxacin as a labeling agent.
Lee JH; Le VH; Lee S; Park JH; Lee JA; Tchah H; Kim S; Kim MJ; Kim KH
Exp Eye Res; 2018 Sep; 174():51-58. PubMed ID: 29787746
[TBL] [Abstract][Full Text] [Related]
4. In vivo 3D measurement of moxifloxacin and gatifloxacin distributions in the mouse cornea using multiphoton microscopy.
Lee S; Lee JH; Park JH; Yoon Y; Chung WK; Tchah H; Kim MJ; Kim KH
Sci Rep; 2016 May; 6():25339. PubMed ID: 27138688
[TBL] [Abstract][Full Text] [Related]
5. Fast and sensitive delineation of brain tumor with clinically compatible moxifloxacin labeling and confocal microscopy.
Lee S; Park WY; Chang H; Kim B; Jang WH; Kim S; Shin Y; Kim MJ; Lee KH; Kim EH; Chung E; Kim KH
J Biophotonics; 2020 Jan; 13(1):e201900197. PubMed ID: 31368257
[TBL] [Abstract][Full Text] [Related]
6. Three-photon tissue imaging using moxifloxacin.
Lee S; Lee JH; Wang T; Jang WH; Yoon Y; Kim B; Jun YW; Kim MJ; Kim KH
Sci Rep; 2018 Jun; 8(1):9415. PubMed ID: 29925864
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ
Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Anti-angiogenic and Anti-inflammatory Effects of Two Antibiotics: Clarithromycin Versus Moxifloxacin.
Uehara H; Das SK; Cho YK; Archer B; Ambati BK
Curr Eye Res; 2016 Apr; 41(4):474-84. PubMed ID: 26125497
[TBL] [Abstract][Full Text] [Related]
9. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Thibodeaux BA; Dajcs JJ; Caballero AR; Marquart ME; Girgis DO; O'Callaghan RJ
Curr Eye Res; 2004 May; 28(5):337-42. PubMed ID: 15287370
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin in uncomplicated skin and skin structure infections.
Muijsers RB; Jarvis B
Drugs; 2002; 62(6):967-73; discussion 974-5. PubMed ID: 11929342
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin, a new antibiotic designed to treat community-acquired respiratory tract infections: a review of microbiologic and pharmacokinetic-pharmacodynamic characteristics.
Nightingale CH
Pharmacotherapy; 2000 Mar; 20(3):245-56. PubMed ID: 10730681
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin Labeling-Based Multiphoton Microscopy of Skin Cancers in Asians.
Chang H; Jang WH; Lee S; Kim B; Kim MJ; Kim WO; Ryoo YW; Oh BH; Kim KH
Lasers Surg Med; 2020 Apr; 52(4):373-382. PubMed ID: 31338864
[TBL] [Abstract][Full Text] [Related]
13. Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection.
Schulte S; Ackermann T; Bertram N; Sauerbruch T; Paar WD
J Chromatogr Sci; 2006 Apr; 44(4):205-8. PubMed ID: 16620519
[TBL] [Abstract][Full Text] [Related]
14. High-speed combined reflectance confocal and moxifloxacin based two-photon microscopy.
Kim B; Le H; Oh BH; Kim KH
Biomed Opt Express; 2020 Mar; 11(3):1555-1567. PubMed ID: 32206428
[TBL] [Abstract][Full Text] [Related]
15. Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis.
Mack RJ; Shott S; Schatz S; Farley SJ
J Ocul Pharmacol Ther; 2009 Jun; 25(3):279-84. PubMed ID: 19348601
[TBL] [Abstract][Full Text] [Related]
16. Safety of moxifloxacin as shown in animal and in vitro studies.
McGee DH; Holt WF; Kastner PR; Rice RL
Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S46-54. PubMed ID: 16257310
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.
Callegan MC; Ramirez R; Kane ST; Cochran DC; Jensen H
Adv Ther; 2003; 20(5):246-52. PubMed ID: 14964344
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the clinical microbiology profile of moxifloxacin.
Krasemann C; Meyer J; Tillotson G
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S51-63. PubMed ID: 11249830
[TBL] [Abstract][Full Text] [Related]
19. Spectrofluorimetric determination of moxifloxacin in tablets, human urine and serum.
Ocaña JA; Barragán FJ; Callejón M
Analyst; 2000 Dec; 125(12):2322-5. PubMed ID: 11219075
[TBL] [Abstract][Full Text] [Related]
20. [In vitro antibiotic susceptibility to fluoroquinolones].
Wong CA; Galvis V; Tello A; Villareal D; Rey JJ
Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
